MACROGENICS, INC. Diluted Shares Outstanding (Weighted Average)
MACROGENICS, INC. (MGNX) reported Diluted Shares Outstanding (Weighted Average) of 63.59 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 63.59M shares, a 0.73% increase year-over-year.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 63.45M shares, a 0.77% increase year-over-year.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 63.28M shares, a 0.79% increase year-over-year.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 63.28M shares, a 0.66% increase year-over-year.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 63.16M shares, a 0.85% increase from fiscal 2024.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 62.62M shares, a 1.12% increase from fiscal 2023.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 61.93M shares, a 0.81% increase from fiscal 2022.
- MACROGENICS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 61.43M shares, a 2.48% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 63.59M shares 10-Q · filed 2026-08-14 | 63.52M shares 10-Q · filed 2026-08-14 | 63.44M shares derived: average of 3 quarters · filed 2026-08-14 | 63.40M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | 63.45M shares 10-Q · filed 2026-05-13 | 63.37M shares derived: average of 2 quarters · filed 2026-05-13 | 63.34M shares derived: average of 3 quarters · filed 2026-05-13 | 63.29M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | 63.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 63.28M shares derived: average of 2 quarters · filed 2026-03-09 | 63.23M shares derived: average of 3 quarters · filed 2026-08-14 | 63.16M shares 10-K · filed 2026-03-09 | |
| 2025-09-30 | 63.28M shares 10-Q · filed 2025-11-12 | 63.21M shares derived: average of 2 quarters · filed 2026-08-14 | 63.11M shares 10-Q · filed 2025-11-12 | 63.04M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | 63.14M shares 10-Q · filed 2026-08-14 | 63.05M shares 10-Q · filed 2026-08-14 | 62.96M shares derived: average of 3 quarters · filed 2026-08-14 | 62.94M shares derived: average of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | 62.97M shares 10-Q · filed 2026-05-13 | 62.87M shares derived: average of 2 quarters · filed 2026-05-13 | 62.87M shares derived: average of 3 quarters · filed 2026-05-13 | 62.82M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 62.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 62.83M shares derived: average of 2 quarters · filed 2026-03-09 | 62.77M shares derived: average of 3 quarters · filed 2026-03-09 | 62.62M shares 10-K · filed 2026-03-09 | |
| 2024-09-30 | 62.87M shares 10-Q · filed 2025-11-12 | 62.76M shares derived: average of 2 quarters · filed 2025-11-12 | 62.57M shares 10-Q · filed 2025-11-12 | 62.32M shares derived: average of 4 quarters · filed 2026-03-09 | |
| 2024-06-30 | 62.66M shares 10-Q · filed 2025-08-14 | 62.48M shares 10-Q · filed 2025-08-14 | 62.13M shares derived: average of 3 quarters · filed 2026-03-09 | 62.16M shares derived: average of 4 quarters · filed 2026-03-09 | |
| 2024-03-31 | 62.29M shares 10-Q · filed 2025-05-13 | 61.87M shares derived: average of 2 quarters · filed 2026-03-09 | 61.99M shares derived: average of 3 quarters · filed 2026-03-09 | 62.06M shares derived: average of 4 quarters · filed 2026-03-09 | |
| 2023-12-31 | 61.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 61.85M shares derived: average of 2 quarters · filed 2026-03-09 | 61.98M shares derived: average of 3 quarters · filed 2026-03-09 | 61.93M shares 10-K · filed 2026-03-09 | |
| 2023-09-30 | 62.24M shares 10-Q · filed 2024-11-05 | 62.25M shares derived: average of 2 quarters · filed 2024-11-05 | 62.09M shares 10-Q · filed 2024-11-05 | 61.97M shares derived: average of 4 quarters · filed 2025-03-20 | |
| 2023-06-30 | 62.26M shares 10-Q · filed 2024-08-06 | 62.03M shares 10-Q · filed 2024-08-06 | 61.88M shares derived: average of 3 quarters · filed 2025-03-20 | 61.77M shares derived: average of 4 quarters · filed 2025-03-20 | |
| 2023-03-31 | 61.81M shares 10-Q · filed 2024-05-09 | 61.69M shares derived: average of 2 quarters · filed 2025-03-20 | 61.61M shares derived: average of 3 quarters · filed 2025-03-20 | 61.55M shares derived: average of 4 quarters · filed 2025-03-20 | |
| 2022-12-31 | 61.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 61.51M shares derived: average of 2 quarters · filed 2025-03-20 | 61.47M shares derived: average of 3 quarters · filed 2025-03-20 | 61.43M shares 10-K · filed 2025-03-20 | |
| 2022-09-30 | 61.46M shares 10-Q · filed 2023-11-06 | 61.42M shares derived: average of 2 quarters · filed 2023-11-06 | 61.39M shares 10-Q · filed 2023-11-06 | 61.37M shares derived: average of 4 quarters · filed 2024-03-07 | |
| 2022-06-30 | 61.38M shares 10-Q · filed 2023-08-09 | 61.35M shares 10-Q · filed 2023-08-09 | 61.33M shares derived: average of 3 quarters · filed 2024-03-07 | 61.29M shares derived: average of 4 quarters · filed 2024-03-07 | |
| 2022-03-31 | 61.32M shares 10-Q · filed 2023-05-09 | 61.31M shares derived: average of 2 quarters · filed 2024-03-07 | 61.26M shares derived: average of 3 quarters · filed 2024-03-07 | 60.96M shares derived: average of 4 quarters · filed 2024-03-07 | |
| 2021-12-31 | 61.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 61.23M shares derived: average of 2 quarters · filed 2024-03-07 | 60.84M shares derived: average of 3 quarters · filed 2024-03-07 | 59.94M shares 10-K · filed 2024-03-07 | |
| 2021-09-30 | 61.17M shares 10-Q · filed 2022-11-03 | 60.62M shares derived: average of 2 quarters · filed 2022-11-03 | 59.49M shares 10-Q · filed 2022-11-03 | 58.67M shares derived: average of 4 quarters · filed 2023-03-15 | |
| 2021-06-30 | 60.07M shares 10-Q · filed 2022-08-08 | 58.64M shares 10-Q · filed 2022-08-08 | 57.84M shares derived: average of 3 quarters · filed 2023-03-15 | 56.99M shares derived: average of 4 quarters · filed 2023-03-15 | |
| 2021-03-31 | 57.20M shares 10-Q · filed 2022-05-03 | 56.72M shares derived: average of 2 quarters · filed 2023-03-15 | 55.97M shares derived: average of 3 quarters · filed 2023-03-15 | 54.48M shares derived: average of 4 quarters · filed 2023-03-15 | |
| 2020-12-31 | 56.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 55.35M shares derived: average of 2 quarters · filed 2023-03-15 | 53.57M shares derived: average of 3 quarters · filed 2023-03-15 | 52.44M shares 10-K · filed 2023-03-15 | |
| 2020-09-30 | 54.46M shares 10-Q · filed 2021-11-02 | 52.24M shares derived: average of 2 quarters · filed 2021-11-02 | 51.18M shares 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | 50.02M shares 10-Q · filed 2021-07-29 | 49.52M shares 10-Q · filed 2021-07-29 | |||
| 2019-12-31 | 48.08M shares 10-K · filed 2022-02-24 | ||||
| 2018-06-30 | 42.15M shares 10-Q · filed 2018-08-07 | 39.56M shares 10-Q · filed 2018-08-07 | 38.64M shares derived: average of 3 quarters · filed 2018-08-07 | 38.18M shares derived: average of 4 quarters · filed 2018-08-07 | |
| 2018-03-31 | 36.94M shares 10-Q · filed 2018-05-07 | 36.89M shares derived: average of 2 quarters · filed 2018-05-07 | 36.85M shares derived: average of 3 quarters · filed 2018-05-07 | 36.58M shares derived: average of 4 quarters · filed 2018-08-07 | |
| 2017-12-31 | 36.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 36.81M shares derived: average of 2 quarters · filed 2018-02-27 | 36.47M shares derived: average of 3 quarters · filed 2018-08-07 | 36.10M shares 10-K · filed 2018-02-27 | |
| 2017-09-30 | 36.78M shares 10-Q · filed 2017-11-08 | 36.28M shares derived: average of 2 quarters · filed 2018-08-07 | 35.85M shares 10-Q · filed 2017-11-08 | 35.59M shares derived: average of 4 quarters · filed 2018-08-07 | |
| 2017-06-30 | 35.78M shares 10-Q · filed 2018-08-07 | 35.37M shares 10-Q · filed 2018-08-07 | 35.20M shares derived: average of 3 quarters · filed 2018-08-07 | 35.09M shares derived: average of 4 quarters · filed 2018-08-07 | |
| 2017-03-31 | 34.96M shares 10-Q · filed 2018-05-07 | 34.91M shares derived: average of 2 quarters · filed 2018-05-07 | 34.86M shares derived: average of 3 quarters · filed 2018-05-07 | 35.15M shares derived: average of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | 34.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 34.81M shares derived: average of 2 quarters · filed 2018-02-27 | 35.21M shares derived: average of 3 quarters · filed 2018-02-27 | 34.69M shares 10-K · filed 2018-02-27 | |
| 2016-09-30 | 34.77M shares 10-Q · filed 2017-11-08 | 35.39M shares derived: average of 2 quarters · filed 2017-11-08 | 34.63M shares 10-Q · filed 2017-11-08 | 33.40M shares derived: average of 4 quarters · filed 2018-02-27 | |
| 2016-06-30 | 36.02M shares 10-Q · filed 2017-08-02 | 35.97M shares 10-Q · filed 2017-08-02 | 32.95M shares derived: average of 3 quarters · filed 2018-02-27 | 33.05M shares derived: average of 4 quarters · filed 2018-02-27 | |
| 2016-03-31 | 34.50M shares 10-Q · filed 2017-05-03 | 31.41M shares derived: average of 2 quarters · filed 2018-02-27 | 32.06M shares derived: average of 3 quarters · filed 2018-02-27 | 31.56M shares derived: average of 4 quarters · filed 2018-02-27 | |
| 2015-12-31 | 28.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 30.83M shares derived: average of 2 quarters · filed 2018-02-27 | 30.57M shares derived: average of 3 quarters · filed 2018-02-27 | 31.80M shares 10-K · filed 2018-02-27 | |
| 2015-09-30 | 33.34M shares 10-Q · filed 2016-11-02 | 31.70M shares derived: average of 2 quarters · filed 2016-11-02 | 32.96M shares 10-Q · filed 2016-11-02 | 30.74M shares derived: average of 4 quarters · filed 2017-02-28 | |
| 2015-06-30 | 30.06M shares 10-Q · filed 2016-08-03 | 31.80M shares 10-Q · filed 2016-08-03 | 29.87M shares derived: average of 3 quarters · filed 2017-02-28 | 29.34M shares derived: average of 4 quarters · filed 2017-02-28 | |
| 2015-03-31 | 31.68M shares 10-Q · filed 2016-05-04 | 29.77M shares derived: average of 2 quarters · filed 2017-02-28 | 29.10M shares derived: average of 3 quarters · filed 2017-02-28 | 28.74M shares derived: average of 4 quarters · filed 2017-02-28 | |
| 2014-12-31 | 27.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 27.80M shares derived: average of 2 quarters · filed 2017-02-28 | 27.75M shares derived: average of 3 quarters · filed 2017-02-28 | 27.38M shares 10-K · filed 2017-02-28 | |
| 2014-09-30 | 27.75M shares 10-Q · filed 2015-11-04 | 27.70M shares derived: average of 2 quarters · filed 2015-11-04 | 27.23M shares 10-Q · filed 2015-11-04 | 10.83M shares derived: average of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | 27.65M shares 10-Q · filed 2015-08-05 | 26.96M shares 10-Q · filed 2015-08-05 | 5.19M shares derived: average of 3 quarters · filed 2016-02-29 | 9.21M shares derived: average of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | 26.26M shares 10-Q · filed 2015-05-06 | -6.04M shares derived: average of 2 quarters · filed 2016-02-29 | 3.06M shares derived: average of 3 quarters · filed 2016-02-29 | 2.60M shares derived: average of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -38.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -8.55M shares derived: average of 2 quarters · filed 2016-02-29 | -5.29M shares derived: average of 3 quarters · filed 2016-02-29 | 6.85M shares 10-K · filed 2016-02-29 | |
| 2013-09-30 | 21.24M shares 10-Q · filed 2014-11-12 | 21.24M shares 10-Q · filed 2013-11-12 | 11.23M shares derived: average of 2 quarters · filed 2014-11-12 | 21.91M shares 10-Q · filed 2014-11-12 | -9.07M shares derived: average of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | 1.22M shares 10-Q · filed 2014-08-05 | 1.18M shares 10-Q · filed 2014-08-05 | -19.18M shares derived: average of 3 quarters · filed 2015-03-03 | -9.01M shares derived: average of 4 quarters · filed 2015-03-03 | |
| 2013-03-31 | 1.15M shares 10-Q · filed 2014-05-06 | -29.38M shares derived: average of 2 quarters · filed 2015-03-03 | -12.42M shares derived: average of 3 quarters · filed 2015-03-03 | ||
| 2012-12-31 | -59.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -19.20M shares derived: average of 2 quarters · filed 2015-03-03 | 1.08M shares 10-K · filed 2015-03-03 | ||
| 2012-09-30 | 21.50M shares 10-Q · filed 2013-11-12 | 21.41M shares 10-Q · filed 2013-11-12 | |||
| 2011-12-31 | 1.03M shares 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |